ATHX, Athersys, Inc.

** ATHX reported grant funding aggregating $3.6 million to further advance its MultiStem product programs and cell therapy platform.

Specifically, ATHX was awarded a SBIR Fast-Track grant of up to $1.9 million from the National Institute of Neurological Disorders and Stroke to develop MultiStem for the treatment of traumatic brain injury (TBI).

ATP Oil & Gas Corporation (NASDAQ:ATPG)

ATPG operates its developments and reduces operating risks with projects that have a close proximity to developed markets for natural gas and oil, such as existing infrastructure of oil and natural gas pipelines and production/processing platforms.

Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) reported DERMACYTE(r) skin care products are now available for purchase on a leading on-line skin care site, www.DermStore.com. This popular beauty product outlet complements the Company’s e-tail site, www.buydermacyte.com, broadening accessibility for consumers and increasing brand awareness.

****************